Is Lifestance Health Group Inc (LFST) overvalued? · P/E 146, rev $1.25B
Lifestance Health Group Inc (LFST) is a medical care facilities company listed on NASDAQ.
This page asks whether Lifestance Health Group Inc (LFST) looks expensive on cached numbers — not a short thesis.
Latest reported LFST revenue for 2024-12-31 was $1.25B. Net income was -$57.4M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. LFST currently screens at market cap $3.35B and trailing P/E 146.2.
LFST currently screens at market cap $3.35B and trailing P/E 146.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LFST 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LFST stock page for the full model, not this heading.
Not investment advice.